Travere Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
TVTX chart
What traders are saying about $TVTX
Latest postsTravere Therapeutics, Inc. news
- Travere Therapeutics, Inc. (TVTX) stock price, news, quote and history
Yahoo Finance UK ·
- Travere Therapeutics, Inc. (TVTX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Travere Therapeutics to Report Third Quarter 2026 Financial Results
Yahoo Finance ·
- Biomarker Data Might Change The Case For Investing In Travere Therapeutics (TVTX)
Simply Wall Street ·
- Travere Therapeutics, Inc. Estimates – NASDAQ:TVTX
TradingView ·
- Travere Therapeutics (TVTX) On New FILSPARI Data Is The Bull Case Still Undervalued
Simply Wall Street ·
- Travere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathy
Yahoo Finance ·
- At week 110, one kidney drug lowered an inflammation marker 45.4%; another raised it 8.7%.
Stock Titan ·
- 10 Health Care Stocks Whale Activity In Today’s Session
Benzinga ·
- AstraZeneca Gets Accelerated FDA Nod for Ultomiris in IgA Nephropathy
Yahoo Finance ·
- Earnings Preview: Travere Therapeutics (TVTX) Q3 Earnings Expected to Decline
Yahoo Finance ·
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
Travere Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $490.7M | $233.2M | $145.2M | $109.5M |
| Net income | -$25.5M | -$321.5M | -$111.4M | -$278.5M |
| Diluted EPS | $-0.29 | $-4.08 | $-1.50 | $-4.37 |
| Total assets (year end) | $605.2M | $594.1M | $788.9M | $672.6M |
| Cash and equivalents (year end) | $93.0M | $58.5M | $58.2M | $61.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Travere Therapeutics, Inc.
- Ticker
- TVTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- CA
- Fiscal year end
- December 31
- SEC CIK
- 1438533
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
Frequently asked questions
What exchange is Travere Therapeutics, Inc. listed on?
Travere Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TVTX.
What industry is Travere Therapeutics, Inc. in?
Travere Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Travere Therapeutics, Inc. headquartered?
Travere Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Travere Therapeutics, Inc.'s fiscal year end?
Travere Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Travere Therapeutics, Inc. report?
Travere Therapeutics, Inc. reported $490.7M in revenue for calendar year 2025, according to its SEC filings.